Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleBasic Science Investigation

Repeatability of 68Ga-PSMA-HBED-CC PET/CT–Derived Total Molecular Tumor Volume

Robert Seifert, Patrick Sandach, David Kersting, Wolfgang P. Fendler, Boris Hadaschik, Ken Herrmann, John J. Sunderland and Janet H. Pollard
Journal of Nuclear Medicine May 2022, 63 (5) 746-753; DOI: https://doi.org/10.2967/jnumed.121.262528
Robert Seifert
1Department of Nuclear Medicine, University of Duisburg–Essen and German Cancer Consortium–University Hospital, Essen, Germany;
2West German Cancer Center, Essen, Germany;
3Department of Nuclear Medicine, University Hospital Münster, University of Münster, Münster, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick Sandach
1Department of Nuclear Medicine, University of Duisburg–Essen and German Cancer Consortium–University Hospital, Essen, Germany;
2West German Cancer Center, Essen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Kersting
1Department of Nuclear Medicine, University of Duisburg–Essen and German Cancer Consortium–University Hospital, Essen, Germany;
2West German Cancer Center, Essen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wolfgang P. Fendler
1Department of Nuclear Medicine, University of Duisburg–Essen and German Cancer Consortium–University Hospital, Essen, Germany;
2West German Cancer Center, Essen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Boris Hadaschik
2West German Cancer Center, Essen, Germany;
4Department of Urology, University Hospital Essen, and German Cancer Consortium–University Hospital, Essen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ken Herrmann
1Department of Nuclear Medicine, University of Duisburg–Essen and German Cancer Consortium–University Hospital, Essen, Germany;
2West German Cancer Center, Essen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John J. Sunderland
5Department of Radiology, University of Iowa Carver College of Medicine, Iowa City, Iowa; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Janet H. Pollard
5Department of Radiology, University of Iowa Carver College of Medicine, Iowa City, Iowa; and
6Department of Radiology, Iowa City Veterans Healthcare Center, Iowa City, Iowa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 63 no. 5 746-753
DOI 
https://doi.org/10.2967/jnumed.121.262528
PubMed 
34446454

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication May 3, 2021
  • Revision received August 5, 2021
  • Published online April 28, 2022.

Article Versions

  • previous version (August 26, 2021 - 10:52).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2022 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Robert Seifert1,2,3,
  2. Patrick Sandach1,2,
  3. David Kersting1,2,
  4. Wolfgang P. Fendler1,2,
  5. Boris Hadaschik2,4,
  6. Ken Herrmann1,2,
  7. John J. Sunderland5 and
  8. Janet H. Pollard5,6
  1. 1Department of Nuclear Medicine, University of Duisburg–Essen and German Cancer Consortium–University Hospital, Essen, Germany;
  2. 2West German Cancer Center, Essen, Germany;
  3. 3Department of Nuclear Medicine, University Hospital Münster, University of Münster, Münster, Germany;
  4. 4Department of Urology, University Hospital Essen, and German Cancer Consortium–University Hospital, Essen, Germany;
  5. 5Department of Radiology, University of Iowa Carver College of Medicine, Iowa City, Iowa; and
  6. 6Department of Radiology, Iowa City Veterans Healthcare Center, Iowa City, Iowa
  1. For correspondence or reprints, contact Robert Seifert (robert.seifert{at}uk-essen.de).
View Full Text

Statistics from Altmetric.com

Cited By...

  • 13 Citations
  • 9 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Evaluation of177Lu-PSMA-617 SPECT/CT Quantitation as a Response Biomarker Within a Prospective177Lu-PSMA-617 and NOX66 Combination Trial (LuPIN)
    Sarennya Pathmanandavel, Megan Crumbaker, Bao Ho, Andrew O. Yam, Peter Wilson, Remy Niman, Maria Ayers, Shikha Sharma, Adam Hickey, Peter Eu, Martin Stockler, Andrew J. Martin, Anthony M. Joshua, Andrew Nguyen, Louise Emmett
    Journal of Nuclear Medicine 2023 64 2
  • The VISION Forward: Recognition and Implication of PSMA−/18F-FDG+ mCRPC
    Hossein Jadvar
    Journal of Nuclear Medicine 2022 63 6
  • Total Tumor Volume on 18F-PSMA-1007 PET as Additional Imaging Biomarker in mCRPC Patients Undergoing PSMA-Targeted Alpha Therapy with 225Ac-PSMA-I&T
    Lena M. Unterrainer, Leonie Beyer, Mathias J. Zacherl, Franz J. Gildehaus, Andrei Todica, Sophie C. Kunte, Adrien Holzgreve, Gabriel T. Sheikh, Annika Herlemann, Jozefina Casuscelli, Matthias Brendel, Nathalie L. Albert, Vera Wenter, Nina-Sophie Schmidt-Hegemann, Wolfgang G. Kunz, Clemens C. Cyran, Jens Ricke, Christian G. Stief, Peter Bartenstein, Harun Ilhan, Marcus Unterrainer
    Biomedicines 2022 10 5
  • Prostate specific membrane antigen positron emission tomography in primary prostate cancer diagnosis: First-line imaging is afoot
    Jianhua Jiao, Jingliang Zhang, Zeyu Li, Weihong Wen, Chaochao Cui, Qiang Zhang, Jing Wang, Weijun Qin
    Cancer Letters 2022 548
  • Deep learning-based whole-body PSMA PET/CT attenuation correction utilizing Pix-2-Pix GAN
    Kevin C. Ma, Esther Mena, Liza Lindenberg, Nathan S. Lay, Phillip Eclarinal, Deborah E. Citrin, Peter A. Pinto, Bradford J. Wood, William L. Dahut, James L. Gulley, Ravi A. Madan, Peter L. Choyke, Ismail Baris Turkbey, Stephanie A. Harmon
    Oncotarget 2024 15 1
  • Reliability of gradient-based segmentation for measuring metabolic parameters influenced by uptake time on 18F-PSMA-1007 PET/CT for prostate cancer
    Yu Ching Lau, Sirong Chen, Chi Lai Ho, Jing Cai
    Frontiers in Oncology 2022 12
  • Whole-body tumor burden in PET/CT expert review
    Dihego F. Santos, Maria Emilia Takahashi, Mariana Camacho, Mariana da Cunha Lopes de Lima, Bárbara Juarez Amorim, Eric M. Rohren, Elba Etchebehere
    Clinical and Translational Imaging 2022 11 1
  • Accuracy of gross tumour volume delineation with [68Ga]-PSMA-PET compared to histopathology for high-risk prostate cancer
    Maryam Zarei, Elin Wallsten, Josefine Grefve, Karin Söderkvist, Adalsteinn Gunnlaugsson, Kristina Sandgren, Joakim Jonsson, Angsana Keeratijarut Lindberg, Erik Nilsson, Anders Bergh, Björn Zackrisson, Mathieu Moreau, Camilla Thellenberg Karlsson, Lars E. Olsson, Anders Widmark, Katrine Riklund, Lennart Blomqvist, Vibeke Berg Loegager, Jan Axelsson, Sara N. Strandberg, Tufve Nyholm
    Acta Oncologica 2024 63
  • Does total lesion prostate‐specific membrane antigen (PSMA) activity on 68Ga‐PSMA PET/CT correlate with PSA and prostatectomy histopathological/clinical outcomes in patients with localised primary prostate cancer?
    Jeremy Cheng, Mohammadmehdi Adhami, Tho Pham, David P. Nadebaum, Ashley Baring, Eldho Paul, Martin Cherk, Jeremy Grummet
    BJUI Compass 2025 6 4

Article usage

Article usage: August 2021 to April 2025

AbstractFullPdf
Aug 2021803024
Sep 2021699025
Oct 202178805
Nov 2021214013
Dec 202119903
Jan 202212305
Feb 202212408
Mar 2022127075
Apr 20222056654
May 202243136393
Jun 202222118335
Jul 2022459926
Aug 2022275713
Sep 20222221217
Oct 2022244914
Nov 2022387729
Dec 20223137614
Jan 20232438118
Feb 20232136332
Mar 20231335622
Apr 20231227019
May 20231116526
Jun 2023723921
Jul 2023722915
Aug 20231631425
Sep 2023727217
Oct 20231511415
Nov 20233910215
Dec 2023386930
Jan 20241717225
Feb 2024619223
Mar 2024512013
Apr 2024255511
May 202496414
Jun 2024265417
Jul 2024786921
Aug 2024696013
Sep 202482822
Oct 202462418
Nov 2024102525
Dec 202473716
Jan 202532716
Feb 2025911811
Mar 202514823
Apr 2025133620
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 63 (5)
Journal of Nuclear Medicine
Vol. 63, Issue 5
May 1, 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Repeatability of 68Ga-PSMA-HBED-CC PET/CT–Derived Total Molecular Tumor Volume
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Repeatability of 68Ga-PSMA-HBED-CC PET/CT–Derived Total Molecular Tumor Volume
Robert Seifert, Patrick Sandach, David Kersting, Wolfgang P. Fendler, Boris Hadaschik, Ken Herrmann, John J. Sunderland, Janet H. Pollard
Journal of Nuclear Medicine May 2022, 63 (5) 746-753; DOI: 10.2967/jnumed.121.262528

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Repeatability of 68Ga-PSMA-HBED-CC PET/CT–Derived Total Molecular Tumor Volume
Robert Seifert, Patrick Sandach, David Kersting, Wolfgang P. Fendler, Boris Hadaschik, Ken Herrmann, John J. Sunderland, Janet H. Pollard
Journal of Nuclear Medicine May 2022, 63 (5) 746-753; DOI: 10.2967/jnumed.121.262528
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • Evaluation of 177Lu-PSMA-617 SPECT/CT Quantitation as a Response Biomarker Within a Prospective 177Lu-PSMA-617 and NOX66 Combination Trial (LuPIN)
  • The VISION Forward: Recognition and Implication of PSMA-/18F-FDG+ mCRPC
  • Google Scholar

More in this TOC Section

  • Establishing In Vitro Dosimetric Models and Dose–Effect Relationships for 177Lu-DOTATATE in Neuroendocrine Tumors
  • Designed Ankyrin Repeat Protein–Mediated Peptide Nucleic Acid–Based Pretargeting: A Proof-of-Principle Study
  • [11C]ZTP-1: An Effective Short-Lived Radioligand for PET of Rat and Monkey Brain Phosphodiesterase Type 4 Subtype B
Show more Basic Science Investigation

Similar Articles

Keywords

  • PSMA PET
  • tumor volume
  • repeatability
SNMMI

© 2025 SNMMI

Powered by HighWire